NEW YORK (GenomeWeb News) – Myriad Genetics' investment into RainDance Technologies totals $5.0 million, the Salt Lake City-based company said in its Form 10-Q filed with the US Securities and Exchange Commission this week.
Registering provides access to this and other free content.
Already have an account?Login Now.
The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.
In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.
A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.
As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.